CD86 and neoplasm: Tregs can suppress costimulatory signal CD80/CD86 expression via CTLA-4, as well as secrete the immunosuppressive cytokine TGF-β and IL-10 to inhibit T cell activation and response, thus mediating tumor immune escape 54, 55.